The document outlines a roadmap to abolish aging by 2040, highlighting the potential efforts of major companies and transformative technologies of the fourth industrial revolution in promoting healthy life extension. It discusses advancements in medicine and geroscience, emphasizing the need for a shift in focus from treating diseases individually to addressing the underlying processes of aging. The document predicts that societal prioritization of rejuvenation biotech could result in the development of affordable and effective therapies, potentially allowing healthy individuals to live significantly longer, healthier lives.